Skip to main content
letter
. 2023 Jan 11;13(1):11. doi: 10.1038/s41408-023-00785-y

Table 1.

Classification based on refractoriness to the number of drugs/drug classes vs lines of therapy.

Number of lines Median PFS (months) Number of drugs/drug classes refractory PFS (number of drugs refractory to) PFS (number of drug classes refractory to)
1 34.2 0 40.3 40.3
2 14.9 1 22.8 21.9
3 11.0 2 14.1 12.9
>=4 5.7 >=3 6.0 6.0
Overall survival
Number of lines Median OS (months) Number of drugs/drug classes refractory OS (number of drugs refractory to) OS (number of drug classes refractory to)
1 92.8 0 NR NR
2 60.2 1 65.0 63.1
3 46.1 2 64.4 61.8
>=4 30.2 >=3 29.5 28.7

PFS progression-free survival, OS overall survival, NR not reached.